Shares of Diplomat Pharmacy (NYSE: DPLO), a distributor of specialty biotechnology and pharmaceutical products, dropped by 37% as of 11:55 a.m. EDT on Thursday after the company reported disappointing third-quarter results.
Image source: Getty Images.